Nobuyoshi Maeji - Anteo Diagnostics Insider

Anteo Diagnostics Limited -- Australia Stock  

AUD 0.03  0.01  50%

Chief Scientific Officer

Dr. Nobuyoshi Joe Maeji, Ph.D., is Founder, Chief Scientific Officer of Anteo Diagnostics Limited. Dr. Joe Maeji is the founder of BioLayer. Prior to forming Bio Layer, Dr. Maeji held the position of Head of Research for Mimotopes Pty Ltd and Sr. Director for Small Molecule Drug Discovery for Chiron. At Mimotopes Pty Ltd., he directed RD, production as well as commercialization of products and technologies during the growth of this company
  Executive Since 2009  Ph.D    
61 7 3219 0085  http://www.anteodx.com
Maeji holds a Ph.D. in Polymer Engineering from the Tokyo Institute of Technology.

Management Efficiency

The company has return on total asset (ROA) of (2.76) % which means that it has lost $2.76 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (45.51) % meaning that it generated substantial loss on money invested by shareholders.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Alden ToevsCommonwealth Bank of Australia
2008
Adam BennettCommonwealth Bank of Australia
N/A
Matthew ComynCommonwealth Bank of Australia
2012
Anna LenahanCommonwealth Bank of Australia
2016
Megan PepperBHP Billiton Limited
2014
John PriestleyAustralia and New Zealand Banki
2004
Gary ThursbyWestpac Banking Corporation
2016
David WhiteingCommonwealth Bank of Australia
2014
Jill CraigAustralia and New Zealand Banki
N/A
Melanie LaingCommonwealth Bank of Australia
2012
Fred OhlssonAustralia and New Zealand Banki
2016
Alexandra HolcombWestpac Banking Corporation
2014
Laura TylerBHP Billiton Limited
2016
Dave BComWestpac Banking Corporation
N/A
Kathryn MerweAustralia and New Zealand Banki
2017
Rachel AgnewBHP Billiton Limited
2014
Kate GriffithsBHP Billiton Limited
2014
Rebecca LimWestpac Banking Corporation
2016
Vittoria ShorttCommonwealth Bank of Australia
N/A
Andrew BowdenWestpac Banking Corporation
N/A
Christine ParkerWestpac Banking Corporation
2011

Entity Summary

Anteo Diagnostics Limited, a medical technology company, develops and commercializes specialized surfaces for use in life sciences industries in Australia. Anteo Diagnostics Limited (ADO) is traded on Australian Securities Exchange in Australia. It is located in Eight Mile Plains, QLD and employs 99 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Anteo Diagnostics Limited to your portfolio

Top Management

Anteo Diagnostics Limited Leadership Team
Nobuyoshi Maeji, Executive, Ph.D
Alan Studley, Director, CPA
Mark Bouris, Chairman
Peter HardingSmith, CFO
John Hurrell, Director, Ph.D
Geoffrey Cumming, CEO
Tamara Mills, COO
Julien McInally, Executive, CPA
Shane Hartwig, Executive
Nevin Abernethy, Executive
Richard Martin, Director
Jef Vangenechten, CEO, Ph.D
Rolf Sickman, Director
Sandra Andersen, Director, CPA

Stock Performance

Anteo Diagnostics Performance Indicators